The data demonstrated that PSMC1-6 presented moderate protein expressions, and PSMC2, PSMC3, and PSMC5 were highly expressed in certain clinical tissues from breast cancer specimens (Figure 5). This evidence concerns the gene PSMC5 and breast carcinoma.